Bellin and two other graduates of the biotechnology master’s program, Joel Andrade MS ’21 and Hannah Hirou MS ’23, are ...

A new cocktail described in the journal Cell fully protected mice against a lethal dose of venom from 13 deadly snake species ...

Tim Friede voluntarily injected himself with venom and endured over 200 snake bites in hopes of building immunity and helping create a universal antivenom. Now, scientists are using antibodies from ...

The antitoxin antibodies found in the blood of a Wisconsin man—who voluntarily let snakes bite him for alm0st 20 years—is helping scientists create better antivenom drugs for snakebites.

Tim Friede, a 57-year-old former truck mechanic, spent 18 years subjecting himself to snake bites and venom injections in an attempt to immunize himself against deadly venom.

What's it like to get bit by a venomous snake? "It's like a bee sting times a thousand," Tim Friede says. Tim would know. Over the past few decades, he's let himself be bitten over 200 times by ...

Tim Friede, pictured here with a water cobra, exposed himself to snake venom over decades. Scientists say they have now made a broadly effective antivenom with the help of his antibodies.

Tim Friede, a man who injected himself with snake venom, helped create an antivenom that can protect mice from venomous snakes. Researchers hope for human clinical trials one day.

Tim Friede, Photo: Centivax . Early disaster. In 2000, he began exposing himself to venom. He started with scorpions but soon changed to snakes. A year later, he let two cobras bite him.

Tim Friede, center, stands in a lab in South San Francisco, Calif., that is using his blood to prepare an antivenom to the bites of various snakes. Centivax via AP.

In the course of their research, the team found a man, Tim Friede, who had been bitten hundreds of times by 16 species of deadly snakes — the poison lethal enough to kill a horse, according to ...

Tim Friede, a man who injected himself with snake venom, helped create an antivenom that can protect mice from venomous snakes. Researchers hope for human clinical trials one day.